Blocking the Negative Effects of Pyridoxine on Patients Receiving Levodopa

作者: George C. Cotzias

DOI: 10.1001/JAMA.1971.03180220084025

关键词:

摘要: To the Editor.— Duvoisin et al 1 reported that administration of pyridoxine may cancel therapeutic and side effects levodopa. This was confirmed in several centers, including our own. 2 Consequently, industry produced marketed a pyridoxine-free preparation (Larobec) which covers needs for vitamins patients receiving While continuing experiments with peripheral metabolic inhibitor D, L-alpha-methyl dopahydrazine or MK 485, 3 we noted diurnal variations performance could be controlled orally administered combinations Such have also diminished striking postprandial reemergence symptoms otherwise experienced by some patients. 2,3 We were thus encouraged to test whether blocked adverse pyridoxine. Pyridoxine (up 100 mg three times each day) given seven at least one week while they ward

参考文章(4)
George C. Cotzias, Metabolic Modification of Some Neurologic Disorders JAMA: The Journal of the American Medical Association. ,vol. 210, pp. 1255- 1262 ,(1969) , 10.1001/JAMA.1969.03160330055011
G. BARTHOLINI, A. PLETSCHER, Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine. Journal of Pharmacy and Pharmacology. ,vol. 21, pp. 323- 324 ,(2011) , 10.1111/J.2042-7158.1969.TB08258.X
George C. Cotzias, Paul S. Papavasiliou, Rosemary Gellene, Modification of Parkinsonism--chronic treatment with L-dopa. The New England Journal of Medicine. ,vol. 280, pp. 337- 345 ,(1969) , 10.1056/NEJM196902132800701
Coté Ld, Duvoisin Rc, Yahr, Pyridoxine reversal of L-dopa effects in Parkinsonism. Transactions of the American Neurological Association. ,vol. 94, pp. 81- ,(1969)